Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Multifunctional Substrate for Early Detection of Oxidative Stress Susceptibility and Application to Parkinson's Disease

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified December 2005 by Hillel Yaffe Medical Center.
Recruitment status was:  Recruiting
Sponsor:
Collaborator:
Technion, Israel Institute of Technology
Information provided by:
Hillel Yaffe Medical Center
ClinicalTrials.gov Identifier:
NCT00271141
First received: December 29, 2005
Last updated: NA
Last verified: December 2005
History: No changes posted
  Purpose
The proposed work is based on the detection of a novel molecule for sensitivity to oxidative stress in humans in venous blood

Condition
Parkinson's Disease
Oxidative Stress

Study Type: Observational
Study Design: Primary Purpose: Screening
Time Perspective: Cross-Sectional
Time Perspective: Retrospective
Official Title: Multifunctional Substrate for Early Detection of Oxidative Stress Susceptibility and Application to Parkinson's Disease

Resource links provided by NLM:


Further study details as provided by Hillel Yaffe Medical Center:

Estimated Enrollment: 500
Study Start Date: May 2005
Estimated Study Completion Date: December 2015
Detailed Description:
Since alterations in mitochondrial functions in platelets and lymphocytes have been detected in Parkinson's disease we plan to monitor the metabolism a a new molecule (LTG) in the blood samples of Parkinson's disease patients and compare them to controls. We shall use 10 cc of venous blood and analyze serum, white blood cells and platelets. We shall not extract nor use DNA.The main purpose is to develop a marker for Parkinson's disease in venous blood.
  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

Parkinson's disease Healthy control -

Exclusion Criteria:

None -

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00271141

Locations
Israel
Hillel Yaffe Medical Center
Hadera, Israel
Sponsors and Collaborators
Hillel Yaffe Medical Center
Technion, Israel Institute of Technology
Investigators
Principal Investigator: Rivka Inzelberg, MD Hillel Yaffe Medical Center
  More Information

ClinicalTrials.gov Identifier: NCT00271141     History of Changes
Other Study ID Numbers: hy11/2005 
Study First Received: December 29, 2005
Last Updated: December 29, 2005
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

Keywords provided by Hillel Yaffe Medical Center:
Parkinson's disease
Oxidative stress
Marker

Additional relevant MeSH terms:
Parkinson Disease
Disease Susceptibility
Parkinsonian Disorders
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Movement Disorders
Neurodegenerative Diseases
Disease Attributes
Pathologic Processes

ClinicalTrials.gov processed this record on December 08, 2016